Author response for 'Immunogenicity of LY2963016 insulin glargine and Lantus® insulin glargine in Chinese patients with type 1 or type 2 diabetes mellitus'

Autor: null Weimin Wang, null Xiang Song, null Ying Lou, null Liying Du, null Dalong Zhu, null Zhiguang Zhou
Rok vydání: 2022
Databáze: OpenAIRE